Search research articles
Contact Us
Filters
Showing results (71-80 of 79) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 79 results.
The Oncologist
|
February 1, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors
Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2025
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors
Blessie Elizabeth Nelson, Filip Janku, Siqing Fu, et al.
The Lancet. Oncology
|
August 7, 2022
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial
Neeta Somaiah, Anthony P Conley, Edwin Roger Parra, et al.
Nature Communications
|
June 17, 2022
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
Sandra P D'Angelo, Allison L Richards, Anthony P Conley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2026
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update
Alice P Chen, Christina L Rosenberger, Nancy Moore, et al.
Frontiers in Oncology
|
October 31, 2022
The immune landscape of undifferentiated pleomorphic sarcoma
Rossana Lazcano, Carmelia M Barreto, Ruth Salazar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
The New England Journal of Medicine
|
September 6, 2023
Atezolizumab for Advanced Alveolar Soft Part Sarcoma
Alice P Chen, Elad Sharon, Geraldine O'Sullivan-Coyne, et al.
Nature Cancer
|
February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 79) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 79 results.
The Oncologist
|
February 1, 2024
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors
Sarina A Piha-Paul, Binghe Xu, Ecaterina E Dumbrava, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 11, 2025
Phase Ib Study of Pembrolizumab in Combination with Intratumoral Injection of Clostridium novyi-NT in Patients with Advanced Solid Tumors
Blessie Elizabeth Nelson, Filip Janku, Siqing Fu, et al.
The Lancet. Oncology
|
August 7, 2022
Durvalumab plus tremelimumab in advanced or metastatic soft tissue and bone sarcomas: a single-centre phase 2 trial
Neeta Somaiah, Anthony P Conley, Edwin Roger Parra, et al.
Nature Communications
|
June 17, 2022
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma
Sandra P D'Angelo, Allison L Richards, Anthony P Conley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 18, 2026
Atezolizumab for Alveolar Soft Part Sarcoma: A Clinical Trial Update
Alice P Chen, Christina L Rosenberger, Nancy Moore, et al.
Frontiers in Oncology
|
October 31, 2022
The immune landscape of undifferentiated pleomorphic sarcoma
Rossana Lazcano, Carmelia M Barreto, Ruth Salazar, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 14, 2023
Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
Roberto Carmagnani Pestana, Justin T Moyers, Jason Roszik, et al.
The New England Journal of Medicine
|
September 6, 2023
Atezolizumab for Advanced Alveolar Soft Part Sarcoma
Alice P Chen, Elad Sharon, Geraldine O'Sullivan-Coyne, et al.
Nature Cancer
|
February 13, 2024
A randomized, non-comparative phase 2 study of neoadjuvant immune-checkpoint blockade in retroperitoneal dedifferentiated liposarcoma and extremity/truncal undifferentiated pleomorphic sarcoma
Christina L Roland, Elise F Nassif Haddad, Emily Z Keung, et al.
Page
of 8